Cargando…
In silico study of fragile histidine triad interaction domains with MDM2 and p53
BACKGROUND: Fragile histidine triad (FHIT) is considered as a member of the histidine triad (HIT) nucleotide-binding protein superfamily regarded as a putative tumor suppressor executing crucial role in inhibiting p53 degradation by MDM2. Accumulating evidences indicate FHIT interaction with p53 or...
Autores principales: | Eslamparast, Ameneh, Ghahremani, Mohammad Hossein, Sardari, Soroush |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162077/ https://www.ncbi.nlm.nih.gov/pubmed/25221773 http://dx.doi.org/10.4103/2277-9175.139178 |
Ejemplares similares
-
N-Terminal Domain of Fragile Histidine Triad Exerts Potent Cytotoxic Effect in HT1080 Cells and Increases Doxorubicin Cytotoxicity
por: Eslamparast, Ameneh, et al.
Publicado: (2019) -
Computational Survey of FHIT, A Putative Human Tumor Suppressor, Truncates Structure
por: Eslamparast, Ameneh, et al.
Publicado: (2014) -
Simulation of Different Truncated p16(INK4a) Forms and In Silico Study of Interaction with Cdk4
por: Fahham, Najmeh, et al.
Publicado: (2008) -
Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev
por: Niu, Zheyun, et al.
Publicado: (2023) -
The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer
por: Liu, Xiao-Ping, et al.
Publicado: (2018)